Diamyd expands its Scientific Advisory Board
Diamyd Medical recently acquired exclusive rights relating to the therapeutic use of GABA for the treatment of diabetes and other inflammation-related conditions. The Company is now expanding its Scientific and Medical Advisory Board with three internationally leading experts on GABA and diabetes: Dr. Bryndis Birnir, Dr. Brooke Ligon, and Dr. Qinghua Wang.Diamyd Medical has for a long time attracted some of the world’s most renowned experts in diabetes and immunology to its Scientific and Medical Advisory Board. The advisory board is an important source of information for the Company, which